Life Technologies Corp Business Finance Contracts & Agreements
11 Contracts & Agreements
- Indenture Agreements (1 contract)
- Note Agreements (4)
- Purchase Agreements (1)
- Share Agreements (2)
- Stock Agreements (3)
- LIFE TECHNOLOGIES CORPORATION NOTICE OF GRANT OF STOCK OPTIONS (Filed With SEC on February 29, 2012)
- - EXECUTION COPY - SHARE SALE AND PURCHASE AGREEMENT (Filed With SEC on August 3, 2005)
- 3.25% CONVERTIBLE SENIOR NOTES DUE 2025 REGISTRATION RIGHTS AGREEMENT DATED AS OF JUNE 20, 2005 by and among (Filed With SEC on June 24, 2005)
- - EXECUTION COPY - SHARE SALE AND PURCHASE AGREEMENT (Filed With SEC on May 6, 2005)
- INVITROGEN CORPORATION 2% CONVERTIBLE SENIOR NOTES DUE 2023 (Filed With SEC on February 23, 2005)
- INVITROGEN CORPORATION 1.5% CONVERTIBLE SENIOR NOTES DUE 2024 INDENTURE DATED AS OF DECEMBER 14, 2004 U.S. BANK NATIONAL ASSOCIATION AS TRUSTEE TABLE OF CONTENTS (Filed With SEC on February 23, 2005)
- INVITROGEN CORPORATION NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Executive Agreement with Deferral of Settlement Date) (Filed With SEC on October 18, 2004)
- INVITROGEN CORPORATION RESTRICTED STOCK AGREEMENT (Filed With SEC on May 10, 2004)
- INVITROGEN CORPORATION 1.5% CONVERTIBLESENIOR NOTES DUE 2024 (Filed With SEC on May 10, 2004)
- $517,500,000 1.5% CONVERTIBLE SENIOR NOTES DUE 2024 REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 10, 2004)
- Asset Purchase Agreement by and among Vertex Pharmaceuticals Incorporated, PanVera LLC and Invitrogen Corporation, dated February 4, 2003 (Filed With SEC on April 11, 2003)
